Terns Pharmaceuticals, Inc. (TERN) Financials
TERN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 268.5 million | 13.2 million |
2023-09-30 | 271.7 million | 13.3 million |
2023-06-30 | 289.7 million | 15.5 million |
2023-03-31 | 301.3 million | 13.6 million |
TERN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -19.4 million | 3.3 million |
2023-09-30 | -20.7 million | 14.1 million |
2023-06-30 | -13.0 million | 4.2 million |
2023-03-31 | -14.4 million | 3.9 million |
TERN Net Income
No data available :(
TERN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 263.4 million | - | 603000 |
2023-09-30 | 266.6 million | - | 770000 |
2023-06-30 | 285.6 million | - | 876000 |
2023-03-31 | 297.5 million | - | 1.0 million |
TERN Shares Outstanding
TERN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 44000 | 17.5 million | 6.6 million | 220000 |
2023-09-30 | 8000 | 14.8 million | 18.4 million | - |
2023-06-30 | - | 14.2 million | 7.0 million | - |
2023-03-31 | - | 17.1 million | 7.1 million | - |
TERN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 220000 |
2023-09-30 | - | 222000 |
2023-06-30 | - | 217000 |
2023-03-31 | - | 222000 |
TERN
Price: $5.44
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -6.83
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 59800
Market Capitalization: 303.2 million